Izotropic Corp. engages in the commercialization of proprietary diagnostic products for breast cancer. It involves in the import and sale of products & services in the field of human diagnostics and therapeutics in the United States. The company was founded by John M. Boone on May 19, 2016 and is headquartered in Surrey, Canada.